NYSE : BHC
Bausch Health Companies Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 8.2 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.07B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.04B |
| Enterprise Value | 21.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 374.27M |
| Shares Outstanding | 374.27M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 10.71% |
| Owned by Institutions (%) | 36.80% |
| Float | 260.87M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 1.89 |
| PS Ratio | 0.28 |
| Forward PS | 0.29 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.66 |
| P/OCF Ratio | 1.40 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | 5.11 |
| EV / EBIT | 7.06 |
| EV / FCF | 11.44 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.56 |
| Quick Ratio | 1.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.85 |
| Debt / FCF | 11.11 |
| Interest Coverage | 1.90 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -11,040.00% |
| Return on Assets (ROA) | 7.22% |
| Return on Invested Capital (ROIC) | 14.74% |
| Return on Capital Employed (ROCE) | 14.57% |
| Weighted Average Cost of Capital (WACC) | 6.04% |
| Revenue Per Employee | $547,438 |
| Profits Per Employee | -$41,429 |
| Employee Count | 20,300 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.91 |
Taxes
| Measure | Value |
|---|
| Income Tax | 475.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +17.24% |
| 50-Day Moving Average | 6.27 |
| 200-Day Moving Average | 5.71 |
| Relative Strength Index (RSI) | 72.52 |
| Average Volume (20 Days) | 4,124,659 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8.24M |
| Short Previous Month | 8.63M |
| Short % of Shares Out | 2.20% |
| Short % of Float | 3.16% |
| Short Ratio (days to cover) | 4.46 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 11.11B |
| Gross Profit | 8.07B |
| Operating Income | 3.02B |
| Pretax Income | -353.00M |
| Net Income | -841.00M |
| EBITDA | 4.17B |
| EBIT | 3.02B |
| Loss Per Share | -$2.25 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.49B |
| Total Debt | 20.72B |
| Net Cash | -18.23B |
| Net Cash Per Share | -$48.71 |
| Equity (Book Value) | -341.00M |
| Book Value Per Share | -3.55 |
| Working Capital | 2.66B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.21B |
| Capital Expenditures | -344.00M |
| Depreciation & Amortization | 1.15B |
| Net Borrowing | -371.00M |
| Free Cash Flow | 1.87B |
| FCF Per Share | $4.98 |
Margins
| Measure | Value |
|---|
| Gross Margin | 72.62% |
| Operating Margin | 27.18% |
| Pretax Margin | -3.18% |
| Profit Margin | -7.57% |
| EBITDA Margin | 37.53% |
| EBIT Margin | 27.18% |
| FCF Margin | 16.78% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | -0.28% |
| Earnings Yield | -27.71% |
| FCF Yield | 60.18% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.00 |
| Price Target Difference | -1.60% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -0.66% |
| EPS Growth Forecast (3Y) | -5.06% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 5, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.43 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |